[1]
R. M. Svoboda, A. M. Glazer, and D. S. Rigel, “31-Gene Expression Profile Assessing Metastatic Risk in Melanoma Patients: Issues Impacting Patient Selection”, J of Skin, vol. 1, no. 3.1, p. s105, Oct. 2017.